Chen Zhi-Wu, Huang Yu, Yang Qin, Li Xianwu, Wei Wei, He Guo-Wei
Cardiovascular Research, Starr Academic Center for Cardiac Surgery, Providence Heart and Vascular Institute and Department of Surgery, Oregon Health and Science University, Portland, USA.
Cardiovasc Res. 2005 Mar 1;65(4):913-20. doi: 10.1016/j.cardiores.2004.11.018.
Urocortin, a potent vasodilator, plays physiological or pathophysiological roles in the cardiovascular system. However, little is known about its action in human vascular tissues. The present study was designed to investigate the vascular effect of urocortin on human internal mammary artery (IMA) in vitro and the possible underlying mechanisms.
Human IMA was obtained from patients undergoing coronary artery bypass grafting. The isolated IMA rings were mounted in organ baths and changes in isometric tension were measured by using Grass force-displacement transducer. Corticortropin-releasing factor-receptors (CRF-R) were also analyzed in the IMA by using RT-PCR analysis.
In 9,11-dideoxy-11alpha,9alpha-epoxy-methanoprostaglandin F(2alpha) (U46619)-precontracted endothelium-intact rings, urocortin induced concentration-dependent relaxations with pD(2) of 8.69+/-0.11 and this effect was markedly reduced in endothelium-denuded rings. Relaxations to urocortin in endothelium-intact rings were attenuated to the same extent after treatment with N(G)-nitro-l-arginine (l-NNA) and 1H-[1,2,4]oxadizolo[4,3-a]quinoxalin-1-one (ODQ). Urocortin-induced relaxations were also inhibited by treatment with putative K(+) channel blockers, such as tetraethylammonium (TEA(+)), charybdotoxin (CTX), and iberiotoxin (IBX). In endothelium-denuded rings, treatment with TEA(+), CTX, or IBX attenuated relaxation to urocortin as well as sodium nitroprusside (SNP). The bands for CRF-R1, CRF-R2alpha, and CRF-R2beta mRNAs were observed in both endothelium-intact and endothelium-denuded human IMA.
Urocortin produced both endothelium-dependent and -independent relaxation in human IMA rings. The endothelium-dependent component primarily involves the release of endothelial nitric oxide (NO) that in turn stimulates Ca(2+)-activated K(+) channels in vascular smooth muscle via cyclic GMP-dependent mechanisms. CRF-R1, CRF-R2alpha, and CRF-R2beta mRNAs are present in the human IMA.
尿皮质素是一种强效血管舒张剂,在心血管系统中发挥生理或病理生理作用。然而,其在人体血管组织中的作用尚不清楚。本研究旨在探讨尿皮质素对人乳内动脉(IMA)的体外血管效应及其潜在机制。
从接受冠状动脉旁路移植术的患者获取人IMA。将分离的IMA环安装在器官浴槽中,使用Grass力位移换能器测量等长张力变化。还通过逆转录聚合酶链反应(RT-PCR)分析在IMA中检测促肾上腺皮质激素释放因子受体(CRF-R)。
在9,11-二脱氧-11α,9α-环氧甲前列腺素F2α(U46619)预收缩的内皮完整环中,尿皮质素诱导浓度依赖性舒张,pD2为8.69±0.11,而在内皮剥脱环中该效应明显减弱。在内皮完整环中,用N(G)-硝基-L-精氨酸(L-NNA)和1H-[1,2,4]恶二唑并[4,3-a]喹喔啉-1-酮(ODQ)处理后,尿皮质素诱导的舒张减弱程度相同。尿皮质素诱导的舒张也受到假定的钾(K+)通道阻滞剂如四乙铵(TEA(+))、蝎毒素(CTX)和iberiotoxin(IBX)处理的抑制。在内皮剥脱环中,用TEA(+)、CTX或IBX处理减弱了对尿皮质素以及硝普钠(SNP)的舒张作用。在人IMA的内皮完整和内皮剥脱组织中均观察到CRF-R1、CRF-R2α和CRF-R2β mRNA条带。
尿皮质素在人IMA环中产生内皮依赖性和非依赖性舒张。内皮依赖性成分主要涉及内皮一氧化氮(NO)的释放,其进而通过环鸟苷酸依赖性机制刺激血管平滑肌中的钙(Ca2+)激活钾(K+)通道。人IMA中存在CRF-R1、CRF-R2α和CRF-R2β mRNA。